M E Risner
Affiliation: GlaxoSmithKline Research and Development
- Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's diseaseM E Risner
World Wide Development, Research and Development, GlaxoSmithKline, Research Triangle Park, NC 27709 3398, USA
Pharmacogenomics J 6:246-54. 2006..These preliminary findings require confirmation in appropriate clinical studies...